首页> 外文期刊>British Journal of Pharmaceutical Research >Design and Characterization of Glyceryl Monostearate Solid Lipid Nanoparticles Prepared by High Shear Homogenization
【24h】

Design and Characterization of Glyceryl Monostearate Solid Lipid Nanoparticles Prepared by High Shear Homogenization

机译:高剪切均质法制备单硬脂酸甘油酯固体脂质纳米粒的设计与表征

获取原文
           

摘要

Aims: The aim of this study was to explore the practicability of preparation of solid lipid nanoparticles of Glyceryl monostearate containing Dibenzoyl peroxide, Erythromycin base, and Triamcinolone acetonide as model drugs. The physicochemical properties of the prepared formulae like particle size, drug entrapment efficiency, drug loading capacity, yield content and in-vitro drug release behavior were also measured. Methodology: Solid lipid nanoparticles loaded with three model lipophilic drugs were prepared by high shear hot homogenization method. The model drugs used are Dibenzoyl peroxide, Erythromycin base, and Triamcinolone acetonide. Glyceryl monostearate was used as lipid core; Tween 20 and Tween 80 were employed as surfactants and lecithin as co-surfactant. Many formulation parameters were controlled to obtain high quality nanoparticles. The prepared solid lipid nanoparticles were evaluated by different standard physical and imaging methods. The efficiency of drug release form prepared formulae was studied using in vitro technique with utilize of dialysis bag technique. The stability of prepared formulae was studied by thermal procedures and infrared spectroscopy. Results: The mean particle diameter measured by laser diffraction technique was (194.6±5.03 to 406.6±15.2 nm) for Dibenzoyl peroxide loaded solid lipid nanoparticles, (220±6.2 to 328.34±2.5) nm for Erythromycin loaded solid lipid nanoparticles and (227.3±2.5 to 480.6±24) nm for Triamcinolone acetonide loaded solid lipid nanoparticles. The entrapment efficiency and drug loading capacity, determined with ultraviolet spectroscopy, were 80.5±9.45% and 0.805±0.093%, for Dibenzoyl peroxide, 96±11.5 and 0.96±0.012 for Triamcinolone acetonide and 94.6±14.9 and 0.946±0.012 for Erythromycin base respectively. It was found that model drugs showed significant faster release patterns when compared with commercially available formulations and pure drugs (p??0.05). Thermal analysis of prepared solid lipid nanoparticles gave indication of solubilization of drugs within lipid matrix. Fourier Transformation Infrared Spectroscopy (FTIR) showed the absence of new bands for loaded solid lipid nanoparticles indicating no interaction between drugs and lipid matrix and being only dissolved in it. Electron microscope of scanning and transmission techniques indicated sphere form of prepared solid lipid nanoparticles with smooth surface with size below 100 nm. Conclusions: Solid lipid nanoparticles with small particle size have high encapsulation efficiency, and relatively high loading capacity for Dibenzoyl peroxide, Erythromycin base, and Triamcinolone acetonide as model drugs can be obtained by this method.
机译:目的:本研究旨在探讨以过氧化二苯甲酰,红霉素碱和曲安奈德为模型药物的单硬脂酸甘油酯固体脂质纳米粒的制备实用性。还测量了所制备配方的理化性质,例如粒度,药物截留效率,药物载量,收率含量和体外药物释放行为。方法:采用高剪切热均质法制备载有三种模型亲脂性药物的固体脂质纳米颗粒。使用的模型药物是过氧化二苯甲酰,红霉素碱和曲安奈德。单硬脂酸甘油酯用作脂质核心;单硬脂酸甘油酯用作脂质核心。吐温20和吐温80被用作表面活性剂,卵磷脂被用作辅助表面活性剂。控制许多配方参数以获得高质量的纳米颗粒。通过不同的标准物理和成像方法评估了制备的固体脂质纳米颗粒。利用体外技术和透析袋技术研究了药物释放形式制备配方的有效性。通过热程序和红外光谱研究了所制备配方的稳定性。结果:通过激光衍射技术测得的平均粒径为:过氧化二苯甲酰负载的固体脂质纳米颗粒为(194.6±5.03至406.6±15.2 nm),红霉素负载的固体脂质纳米颗粒为(220±6.2至328.34±2.5)nm和(227.3±)载有曲安奈德的固体脂质纳米颗粒的粒径为2.5至480.6±24)nm。紫外分光光度法测定的包封率和载药量分别为过氧化二苯甲酰为80.5±9.45%和0.805±0.093%,曲安奈德为丙酮酸分别为96±11.5和0.96±0.012和红霉素碱为94.6±14.9和0.946±0.012。 。已发现,与市售制剂和纯药物相比,模型药物显示出明显更快的释放方式(p ?? 0.05)。制备的固体脂质纳米颗粒的热分析表明了药物在脂质基质中的溶解。傅里叶变换红外光谱(FTIR)显示,对于负载的固体脂质纳米颗粒没有新的谱带,表明药物与脂质基质之间没有相互作用,仅溶解在其中。扫描和透射技术的电子显微镜显示了制备的固体脂质纳米颗粒的球形形式,其表面光滑且尺寸小于100 nm。结论:该方法制备的固体脂质纳米粒粒径小,具有较高的包封率,且对过氧化二苯甲酰,红霉素碱和曲安奈德为模型药物具有较高的负载量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号